Loading...
New-onset graves’ disease after the initiation of nivolumab therapy for gastric cancer: a case report
BACKGROUND: Immune checkpoint inhibitors (ICIs) can induce immune-related adverse events (irAEs) including thyroid dysfunction. There are only a few reports on Graves’ disease induced by ICIs. We report a case of new-onset Graves’ disease after the initiation of nivolumab therapy in a patient receiv...
Na minha lista:
| Udgivet i: | BMC Endocr Disord |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7449083/ https://ncbi.nlm.nih.gov/pubmed/32847555 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-020-00613-5 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|